American Kratom Association - Page 1

FDA Issues Safety Alert on Kratom Product; American Kratom Association Responds

The association is calling for increased transparency on the alert.

August 24, 2024

Richard Ortega, Associate Editor, WholeFoods Magazine

The American Kratom Association says drawing misinformed conclusions about kratom is hurting the industry and the products being sold.

Top view of Kratom powder in ceramic spoon and Kratom capsules on wooden table.

Study Explores Interaction of Kratom and Cannabidiol

Get highlights of the latest findings from the University of Florida, Gainesville

May 20, 2024

WholeFoods Magazine Staff

A study from the University of Florida, Gainesville, explored the effects of using kratom and cannabidiol (CBD) together.

American Kratom Association Issues Consumer Advisory, Urges FDA to Regulate Kratom

The action comes in wake of product liability lawsuits.

August 22, 2023

Maggie Jaqua, Content Director

The American Kratom Association (AKA) has issued a Consumer Advisory in response to recent wrongful death jury awards in Florida and elsewhere.

Consumer Protection Group Advocates for Responsible Legislation of Kratom

The AKA is working to prevent criminalization, enact proactive legislation to protect the rights of kratom consumers, and ensure that consumers have access to safe products.

July 27, 2023

Maggie Jaqua, Content Director

The American Kratom Association (AKA) is raising awareness about efforts to safeguard the millions of Americans who use kratom products.

Kratom at Center of Wrongful Death Lawsuit

November 11, 2022

Maggie Jaqua, Content Director

Atlanta, GA—A wrongful death lawsuit has been filed in Georgia against individuals, companies, and organizations connected to the manufacturing, marketing, and sale of kratom, according to the Associated Press (AP). The suit was filed by Dana and John Pope followed the death of their 23-year-old son, Ethan Pope. As AP reports,...

WHO Decides Against Scheduling Kratom

December 17, 2021

Julia Peterman

The World Health Organization (WHO) has decided against a critical review and subsequent scheduling of kratom, according to the WHO Expert Committee on Drug Dependence (ECDD) Summary assessments, findings, and recommendations. The ECDD looked at seven substances: Brorphine, Metonitazene, Eutylone, 4F-MDMB-BICA, Benzylone, Kratom, and Phenibut. The first two were added...